Technical Analysis for TSBX - Turnstone Biologics Corp.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Fell Below 20 DMA | Bearish | 1.15% | |
| Fell Below 200 DMA | Bearish | 1.15% | |
| Fell Below 50 DMA | Bearish | 1.15% | |
| 180 Bearish Setup | Bearish Swing Setup | 1.15% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 4 hours ago |
| Possible NR7 | about 6 hours ago |
| Possible Inside Day | about 6 hours ago |
| Gap Up Partially Closed | about 10 hours ago |
| Gapped Up (Partial) | about 10 hours ago |
Get a Trading Assistant
- Earnings date: 02/28/2024
Turnstone Biologics Corp. Description
Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy. Turnstone’s innovative TIL therapy is based upon the identification, selection, and expansion of the most potent tumor-reactive T cells, known as Selected TILs, and is designed to overcome the limitations of first-generation bulk TILs that have demonstrated objective responses only in limited tumor types. Turnstone’s most advanced program, TIDAL-01, is currently being evaluated in two Phase 1 studies in patients with melanoma, breast cancer, and colorectal cancer, and the Company is also actively advancing its preclinical pipeline programs including TIDAL-02, its next Selected TIL program, and its TIDAL-01 and viral immunotherapy combination program.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Solid Tumors Immunotherapy Breast Cancer Melanoma Colorectal Cancer Tumor Infiltrating Lymphocytes
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.2 |
| 52 Week Low | 1.625 |
| Average Volume | 155,874 |
| 200-Day Moving Average | 2.84 |
| 50-Day Moving Average | 2.79 |
| 20-Day Moving Average | 2.78 |
| 10-Day Moving Average | 2.78 |
| Average True Range | 0.21 |
| RSI (14) | 44.75 |
| ADX | 13.76 |
| +DI | 19.32 |
| -DI | 16.07 |
| Chandelier Exit (Long, 3 ATRs) | 2.41 |
| Chandelier Exit (Short, 3 ATRs) | 3.19 |
| Upper Bollinger Bands | 2.97 |
| Lower Bollinger Band | 2.59 |
| Percent B (%b) | 0.17 |
| BandWidth | 13.69 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.0028 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.82 | ||||
| Resistance 3 (R3) | 2.83 | 2.79 | 2.79 | ||
| Resistance 2 (R2) | 2.79 | 2.75 | 2.78 | 2.78 | |
| Resistance 1 (R1) | 2.72 | 2.72 | 2.70 | 2.71 | 2.77 |
| Pivot Point | 2.68 | 2.68 | 2.67 | 2.67 | 2.68 |
| Support 1 (S1) | 2.61 | 2.64 | 2.59 | 2.60 | 2.53 |
| Support 2 (S2) | 2.57 | 2.61 | 2.56 | 2.52 | |
| Support 3 (S3) | 2.50 | 2.57 | 2.51 | ||
| Support 4 (S4) | 2.49 |
